ATE204851T1 - Verfahren zur herstellung von retrovial protease hemmenden zwischenprodukten - Google Patents

Verfahren zur herstellung von retrovial protease hemmenden zwischenprodukten

Info

Publication number
ATE204851T1
ATE204851T1 AT96903641T AT96903641T ATE204851T1 AT E204851 T1 ATE204851 T1 AT E204851T1 AT 96903641 T AT96903641 T AT 96903641T AT 96903641 T AT96903641 T AT 96903641T AT E204851 T1 ATE204851 T1 AT E204851T1
Authority
AT
Austria
Prior art keywords
protease
retrovial
producing
intermediate products
inhibitor
Prior art date
Application number
AT96903641T
Other languages
English (en)
Inventor
John S Ng
Claire A Przybyla
Shu-Hong Zhang
Original Assignee
Searle & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Searle & Co filed Critical Searle & Co
Application granted granted Critical
Publication of ATE204851T1 publication Critical patent/ATE204851T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/10—Separation; Purification; Stabilisation; Use of additives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/04—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated
    • C07C215/06—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic
    • C07C215/18—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic with hydroxy groups and at least two amino groups bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/22—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated
    • C07C215/26—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/22—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated
    • C07C215/28—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/20—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/04—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms
    • C07C275/20—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
    • C07C275/24—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Epoxy Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
AT96903641T 1995-01-20 1996-01-18 Verfahren zur herstellung von retrovial protease hemmenden zwischenprodukten ATE204851T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/376,340 US5831117A (en) 1995-01-20 1995-01-20 Method of preparing retroviral protease inhibitor intermediates
PCT/US1996/000918 WO1996022275A1 (en) 1995-01-20 1996-01-18 Method of preparing retroviral protease inhibitor intermediates

Publications (1)

Publication Number Publication Date
ATE204851T1 true ATE204851T1 (de) 2001-09-15

Family

ID=23484633

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96903641T ATE204851T1 (de) 1995-01-20 1996-01-18 Verfahren zur herstellung von retrovial protease hemmenden zwischenprodukten

Country Status (16)

Country Link
US (7) US5831117A (de)
EP (1) EP0804410B1 (de)
JP (1) JP3978229B2 (de)
KR (1) KR100385013B1 (de)
CN (1) CN1623977A (de)
AT (1) ATE204851T1 (de)
AU (1) AU692062B2 (de)
BR (1) BR9606981A (de)
CA (1) CA2210973C (de)
DE (1) DE69614824T2 (de)
DK (1) DK0804410T3 (de)
ES (1) ES2162650T3 (de)
HU (1) HUP9702403A3 (de)
NZ (1) NZ302072A (de)
PT (1) PT804410E (de)
WO (1) WO1996022275A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5831117A (en) * 1995-01-20 1998-11-03 G. D. Searle & Co. Method of preparing retroviral protease inhibitor intermediates
JP2003528071A (ja) * 2000-03-23 2003-09-24 エラン ファーマスーティカルズ インコーポレイテッド アルツハイマー病治療用組成物および方法
US6992081B2 (en) 2000-03-23 2006-01-31 Elan Pharmaceuticals, Inc. Compounds to treat Alzheimer's disease
US6846813B2 (en) * 2000-06-30 2005-01-25 Pharmacia & Upjohn Company Compounds to treat alzheimer's disease
US20030096864A1 (en) * 2000-06-30 2003-05-22 Fang Lawrence Y. Compounds to treat alzheimer's disease
EP1666452A2 (de) 2000-06-30 2006-06-07 Elan Pharmaceuticals, Inc. Verbindungen zur Behandlung der Alzheimerischen Krankheit
PE20020276A1 (es) 2000-06-30 2002-04-06 Elan Pharm Inc COMPUESTOS DE AMINA SUSTITUIDA COMO INHIBIDORES DE ß-SECRETASA PARA EL TRATAMIENTO DE ALZHEIMER
JP2004502665A (ja) * 2000-06-30 2004-01-29 イーラン　ファーマスーティカルズ、インコーポレイテッド アルツハイマー病を治療する化合物
WO2003002122A1 (en) * 2001-06-27 2003-01-09 Elan Pharmaceuticals, Inc. Beta-hydroxyamine derivatives useful in treatment of alzheimer's disease
US20070213407A1 (en) * 2001-06-29 2007-09-13 Elan Pharmaceuticals And Pharmacia & Upjohn Company Llc Compounds to treat Alzheimer's disease
US6867302B2 (en) * 2001-07-13 2005-03-15 Board Of Trustees Of Michigan State University Process for the catalytic synthesis of biaryls and polymers from aryl compounds
EP1562897B1 (de) 2002-11-12 2009-09-16 Merck & Co., Inc. Phenylcarboxamide als beta-sekretase-hemmer zur behandlung von alzheimer
TWI385173B (zh) 2005-11-28 2013-02-11 Tibotec Pharm Ltd 作為ｈｉｖ蛋白酶抑制劑之經取代的胺基苯基磺醯胺化合物
CA2724450A1 (en) * 2008-05-19 2009-11-26 Takeshi Tsubuki Method for producing optically active aminoalcohol derivative
CN116675613B (zh) * 2023-08-03 2023-10-10 北京元延医药科技股份有限公司 手性拆分制备重酒石酸去甲肾上腺素的方法

Family Cites Families (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4268688A (en) 1973-02-16 1981-05-19 Monsanto Company Asymmetric hydroformylation process
JPS5825677B2 (ja) 1977-09-26 1983-05-28 武田薬品工業株式会社 ３−テトラゾ−ル−１−アザキサントン誘導体およびその製造法
US5142056A (en) 1989-05-23 1992-08-25 Abbott Laboratories Retroviral protease inhibiting compounds
US4477414A (en) 1981-05-20 1984-10-16 Fumakilla Limited Evaporative container
EP0068378B1 (de) * 1981-06-26 1986-03-05 Schering Corporation Imidazo(1,2-a)pyridine und -pyrazine, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
EP0104041B1 (de) 1982-09-15 1988-07-27 Aktiebolaget Hässle Enzyminhibitoren
US4668770A (en) 1982-12-27 1987-05-26 Merck & Co., Inc. Renin inhibitory tripeptides
AU573735B2 (en) 1983-02-07 1988-06-23 Aktiebolaget Hassle Peptide analogue enzyme inhibitors
JPS59227851A (ja) 1983-06-09 1984-12-21 Sankyo Co Ltd レニン阻害作用を有するペプチド類
US4514391A (en) 1983-07-21 1985-04-30 E. R. Squibb & Sons, Inc. Hydroxy substituted peptide compounds
US4477441A (en) 1983-09-14 1984-10-16 Merck & Co., Inc. Renin inhibitors containing a C-terminal disulfide cycle
US4645759A (en) 1984-06-22 1987-02-24 Abbott Laboratories Renin inhibiting compounds
US4749792A (en) * 1984-09-26 1988-06-07 E. R. Squibb & Sons, Inc. Diamino ketones and alcohols as analgesic agents
US4616088A (en) 1984-10-29 1986-10-07 E. R. Squibb & Sons, Inc. Amino acid ester and amide renin inhibitor
CN1003504B (zh) 1984-12-03 1989-03-08 三井东圧化学有限公司 氯气制备方法
US4826815A (en) * 1985-05-17 1989-05-02 Abbott Laboratories Renin inhibiting compounds
US4668769A (en) 1985-08-02 1987-05-26 Hoover Dennis J Oxa- and azahomocyclostatine polypeptides
US4599198A (en) 1985-08-02 1986-07-08 Pfizer Inc. Intermediates in polypeptide synthesis
CA1282549C (en) 1985-11-12 1991-04-02 Eric M. Gordon Aminocarbonyl renin inhibitors
US4757050A (en) 1985-12-23 1988-07-12 E. R. Squibb Sons, Inc. Ureido renin inhibitors
CA1297631C (en) 1985-12-23 1992-03-17 Sesha I. Natarajan Ureido renin inhibitors
US4857507A (en) * 1986-04-11 1989-08-15 Abbott Laboratories Angiotensinogen analogs
US4880938A (en) * 1986-06-16 1989-11-14 Merck & Co., Inc. Amino acid analogs
DE3635907A1 (de) 1986-10-22 1988-04-28 Merck Patent Gmbh Hydroxy-aminosaeurederivate
GB2200115B (en) * 1987-01-21 1990-11-14 Sandoz Ltd Novel peptide derivatives, their production and use
DE3800591A1 (de) 1987-01-21 1988-08-04 Sandoz Ag Neue peptidderivate, ihre herstellung und verwendung
USH725H (en) 1987-02-26 1990-01-02 E. R. Squibb & Sons, Inc. Ureido amino and imino acids, compositions and methods for use
GB8707412D0 (en) 1987-03-27 1987-04-29 Fujisawa Pharmaceutical Co Peptide compounds
DE3711911A1 (de) 1987-04-08 1988-10-20 Bayer Ag Optisch aktive (alpha)-aminoaldehyde, verfahren zu ihrer herstellung und ihre verwendung zur stereoselektiven herstellung optisch aktiver ss-aminoalkohole
DE3830825A1 (de) 1987-09-15 1989-03-23 Sandoz Ag Hydrophile reninhemmer, ihre herstellung und verwendung
DE3800059A1 (de) * 1988-01-04 1989-07-13 Paul Merkle Modulo-10-zaehler fuer beide zaehl-richtungen
IL89900A0 (en) 1988-04-12 1989-12-15 Merck & Co Inc Hiv protease inhibitors useful for the treatment of aids and pharmaceutical compositions containing them
US4977277A (en) 1988-05-09 1990-12-11 Abbott Laboratories Functionalized peptidyl aminodiols and -triols 4-amino-5-cyclohexyl-3-hydroxy-1,2-oxopentane and derivatives thereof
IL90218A0 (en) 1988-05-13 1989-12-15 Abbott Lab Retroviral protease inhibitors
CA1340588C (en) 1988-06-13 1999-06-08 Balraj Krishan Handa Amino acid derivatives
IL91307A0 (en) 1988-08-24 1990-03-19 Merck & Co Inc Hiv protease inhibitors and pharmaceutical compositions for the treatment of aids containing them
CA2012306A1 (en) 1989-03-28 1990-09-28 Werner Neidhart Amino acid derivatives
DE3912829A1 (de) 1989-04-19 1990-10-25 Bayer Ag Verwendung von renininhibitorischen peptiden als mittel gegen retroviren
TW225540B (de) 1990-06-28 1994-06-21 Shionogi & Co
JPH05508855A (ja) 1990-07-06 1993-12-09 スミスクライン・ビーチャム・コーポレイション レトロウイルスプロテアーゼ阻害剤
ATE296624T1 (de) 1990-11-19 2005-06-15 Monsanto Co Retrovirusprotease inhibitoren
AU4253193A (en) 1992-05-20 1993-12-13 G.D. Searle & Co. Urea-containing hydroxyethylamine compounds as retroviral protease inhibitors
JP3657002B2 (ja) 1992-08-25 2005-06-08 ジー．ディー．サール アンド カンパニー レトロウイルスプロテアーゼ阻害剤として有用なα−およびβ−アミノ酸ヒドロキシエチルアミノスルホンアミド
IS2334B (is) 1992-09-08 2008-02-15 Vertex Pharmaceuticals Inc., (A Massachusetts Corporation) Aspartyl próteasi hemjari af nýjum flokki súlfonamíða
ES2061380B1 (es) 1992-11-23 1995-07-01 Boehringer Ingelheim Espana Empleo del factor de crecimiento fibroblastico y sus derivados como neuroprotectores y neuromoduladores.
US5484926A (en) * 1993-10-07 1996-01-16 Agouron Pharmaceuticals, Inc. HIV protease inhibitors
US5514801A (en) * 1992-12-29 1996-05-07 Monsanto Company Cyclic sulfone containing retroviral protease inhibitors
DE59401846D1 (de) * 1993-07-15 1997-04-03 Hoffmann La Roche Verfahren zur Herstellung eines N-tert.Butylisochinolin-3-carboxamid Derivates und Zwischenprodukte in diesem Verfahren
WO1995014653A1 (en) 1993-11-23 1995-06-01 G.D. Searle & Co. Method for making intermediates useful in synthesis of retroviral protease inhibitors
JP2996459B2 (ja) * 1994-07-14 1999-12-27 ダイワ精工株式会社 ゴルフクラブヘッド
US5831117A (en) * 1995-01-20 1998-11-03 G. D. Searle & Co. Method of preparing retroviral protease inhibitor intermediates
US6849670B2 (en) * 2000-07-19 2005-02-01 Tokuyama Corporation Photo-curable reparative material for dental use
US20040162679A1 (en) 2002-05-03 2004-08-19 Linheng Li Method for predicting gene potential and cell commitment

Also Published As

Publication number Publication date
HUP9702403A3 (en) 1999-10-28
KR19980701545A (ko) 1998-05-15
AU692062B2 (en) 1998-05-28
ES2162650T3 (es) 2002-01-01
DK0804410T3 (da) 2001-11-26
KR100385013B1 (ko) 2003-08-19
EP0804410B1 (de) 2001-08-29
US20030171612A1 (en) 2003-09-11
WO1996022275A1 (en) 1996-07-25
PT804410E (pt) 2002-01-30
US5831117A (en) 1998-11-03
US20060270855A1 (en) 2006-11-30
JPH10512571A (ja) 1998-12-02
US6201150B1 (en) 2001-03-13
DE69614824D1 (de) 2001-10-04
US6849760B2 (en) 2005-02-01
HUP9702403A2 (hu) 1999-09-28
US20010047111A1 (en) 2001-11-29
BR9606981A (pt) 1997-11-04
CA2210973C (en) 2007-08-07
EP0804410A1 (de) 1997-11-05
JP3978229B2 (ja) 2007-09-19
US6515162B2 (en) 2003-02-04
NZ302072A (en) 1999-01-28
DE69614824T2 (de) 2002-04-11
US7060851B2 (en) 2006-06-13
CA2210973A1 (en) 1996-07-25
CN1623977A (zh) 2005-06-08
AU4765396A (en) 1996-08-07
US20070015818A1 (en) 2007-01-18
US20050131075A1 (en) 2005-06-16

Similar Documents

Publication Publication Date Title
ATE148113T1 (de) Retrovirale protease inhibitoren, enthaltend cyclische sulfone
DE69614824D1 (de) Verfahren zur herstellung von retrovial protease hemmenden zwischenprodukten
ATE215062T1 (de) Verfahren zur herstellung von cyclohexen- carboxylatderivate
DE60320362D1 (de) Verfahren zur Herstellung von Dipeptiden
ATE449104T1 (de) Verfahren zur reinigung von fibrinogen
ATE354648T1 (de) Verfahren zur herstellung eines virus inaktivierten thrombin präparates
ATE202483T1 (de) Immuntolerante prothrombinkomplex-präparation
DE69824839D1 (de) Verfahren zur herstellung von 2-aryl-3-aryl-5-halogen-pyridinen, verwendbar als cox-2 inhibitoren
ATE404674T1 (de) Verfahren zur herstellung von ergosterol und dessen zwischenprodukten mittels rekombinanter hefen
DE69808475D1 (de) Aminosäurederivate zur behandlung von schlaganfall
DE69614899D1 (de) Verfahren zur Herstellung von Aryl-alkyl-hydroperoxiden
WO1997008934A3 (en) Aryl acrylic acid derivatives useful as protein tyrosine phosphatase inhibitors
DE60213874D1 (de) Verfahren zur herstellung von protease hemmenden zwischenprodukten
DE60309847D1 (de) Zwischenprodukte und verfahren zur herstellung von heptapeptid-oxytocinanaloga
DE60015563D1 (de) Verfahren zur herstellung von benzoperhydroisoindolen
ATE299851T1 (de) Verfahren zur herstellung von zwischenprodukten
ATE325794T1 (de) Verfahren zur herstellung und zwischenprodukte von pyridin-2-yl-amin
DE50110561D1 (de) Non-metallocene, verfahren zur herstellung von diesen und deren verwendung zur polymerisation von olefinen
BG98888A (en) Method for the preparation of 3-acylestratrienes and acylbezenes
DE59802620D1 (de) Verfahren zur Herstellung von trans-(R,R)-Actinol
DE60108105D1 (de) Verfahren zur Herstellung von 5-substituierten Isobenzofuranen
DE59808476D1 (de) VERFAHREN ZUR HERSTELLUNG VON ARZNEIMITTELN, ENTHALTEND HMG-CoA- REDUKTASEINHIBITOREN
DE59405085D1 (de) Verfahren zur Herstellung von Tetrachlor-1,4-benzochinon
ATE361913T1 (de) Verfahren und zwischenprodukte zur herstellung von retroviralen proteaseinhibitoren
ATE425143T1 (de) Verfahren zur herstellung von indolen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee